However, past innovation mainly concentrated around heated targets, leading to the rising concern of homogeneous competition for pharmas in China
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 18 of 58
The slide highlights the 'me-too' drug development problem in China.
Consulting deck · market_landscape · frame_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 quote 2/2 source-note 1/1 title 2/2
Components 6
bar-vertical testimonial testimonial source-note headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.